Search all trials

Find therapies in clinical trials near you – page 49

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Glomerulonephritis membranous

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Obinutuzumab and Tacrolimus for Patients with Primary Membranous Nephropathy

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Obinutuzumab

Contact Research Centre

Rheumatoid arthritis

Not recruiting

Investigational

Study on Rosnilimab for Patients with Moderate to Severe Rheumatoid Arthritis

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Rosnilimab

Contact Research Centre

B-cell lymphoma

Not recruiting

InvestigationalNo placebo

Long-term Study of Zanubrutinib for Patients with B-cell Blood Cancer

InvestigationalNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Zanubrutinib

Contact Research Centre

Prodromal Alzheimer's disease

Not recruiting

Registered drug

Study of RO7269162 in people at risk for or with early-stage Alzheimer's Disease: Effects on brain amyloid buildup

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Florbetaben (18F)

Contact Research Centre

Triple negative breast cancer

Not recruiting

Registered drugNo placebo

Study of Datopotamab Deruxtecan and Durvalumab for Adults with Untreated Triple-Negative or Hormone Receptor-Low/HER2-Negative Breast Cancer

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Chronic lymphocytic leukaemia+1

Not recruiting

Registered drugNo placebo

Study Comparing Acalabrutinib and Venetoclax with Venetoclax and Obinutuzumab for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Acalabrutinib

Contact Research Centre

Pneumococcal infection

Not recruiting

Registered drugNo placebo

Study on the Safety and Immune Response of V116 Vaccine in Children and Adolescents at Higher Risk for Pneumococcal Disease

Registered drugNo placebo

Poland

Participants:0–17 years
Substances:Abc-15A-116

Contact Research Centre

Renal cell carcinoma

Not recruiting

Registered drug

Study of V940 and Pembrolizumab for Patients with Renal Cell Carcinoma After Surgery

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Mrna-4157

Contact Research Centre

Systemic lupus erythematosus

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Obinutuzumab for Patients with Systemic Lupus Erythematosus

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Obinutuzumab

Contact Research Centre

Renal cell carcinoma

Not recruiting

Registered drugNo placebo

Study of Belzutifan with Lenvatinib versus Cabozantinib in Adults with Advanced Renal Cell Carcinoma Who Have Previously Received Anti-PD-1/L1 Treatment

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Belzutifan

Contact Research Centre

HIV infection

Not recruiting

Investigational

Study on Budigalimab and ABBV-382 for People with HIV on Stable Antiretroviral Therapy

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Budigalimab

Contact Research Centre

Squamous cell carcinoma of lung+3

Not recruiting

Registered drugNo placebo

Study Comparing Subcutaneous and Intravenous Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Find therapies in clinical trials near you – page 49

723 trials match your criteria

Glomerulonephritis membranous

Study on the Effectiveness and Safety of Obinutuzumab and Tacrolimus for Patients with Primary Membranous Nephropathy

Rheumatoid arthritis

Study on Rosnilimab for Patients with Moderate to Severe Rheumatoid Arthritis

B-cell lymphoma

Long-term Study of Zanubrutinib for Patients with B-cell Blood Cancer

Prodromal Alzheimer's disease

Study of RO7269162 in people at risk for or with early-stage Alzheimer's Disease: Effects on brain amyloid buildup

Triple negative breast cancer

Study of Datopotamab Deruxtecan and Durvalumab for Adults with Untreated Triple-Negative or Hormone Receptor-Low/HER2-Negative Breast Cancer

Chronic lymphocytic leukaemia+1

Study Comparing Acalabrutinib and Venetoclax with Venetoclax and Obinutuzumab for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Pneumococcal infection

Study on the Safety and Immune Response of V116 Vaccine in Children and Adolescents at Higher Risk for Pneumococcal Disease

Renal cell carcinoma

Study of V940 and Pembrolizumab for Patients with Renal Cell Carcinoma After Surgery

Systemic lupus erythematosus

Study on the Effectiveness and Safety of Obinutuzumab for Patients with Systemic Lupus Erythematosus

Renal cell carcinoma

Study of Belzutifan with Lenvatinib versus Cabozantinib in Adults with Advanced Renal Cell Carcinoma Who Have Previously Received Anti-PD-1/L1 Treatment

HIV infection

Study on Budigalimab and ABBV-382 for People with HIV on Stable Antiretroviral Therapy

Squamous cell carcinoma of lung+3

Study Comparing Subcutaneous and Intravenous Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.